CYTOMX THERAPEUTICS I
1.0000
07-November-24 15:59:50
15 minutes delayed
Stocks
0.0000
0.00%
Today's range
0.9882 - 1.0800
ISIN
N/A
Source
NASDAQ
-
17 Nov 2022 07:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
08 Nov 2022 16:10:00 By Nasdaq GlobeNewswire
-
07 Nov 2022 16:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming November Investor Conferences
02 Nov 2022 16:15:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Third Quarter 2022 Financial Results on November 8, 2022
01 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Phase 1 Data Update for anti-CTLA-4 Probody® Therapeutic BMS-986249
12 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
07 Sep 2022 18:05:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
04 Aug 2022 16:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming Virtual August Investor Conferences
03 Aug 2022 08:00:02 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022
28 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Provides Strategic Update
13 Jul 2022 16:05:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Phase 2 Results for Praluzatamab Ravtansine in Breast Cancer
06 Jul 2022 16:05:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces New Employment Inducement Grants
16 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Jefferies 2022 Global Healthcare Conference
01 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
26 May 2022 08:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
05 May 2022 16:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report First Quarter 2022 Financial Results on May 5, 2022
28 Apr 2022 08:00:02 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Retirement of John A. Scarlett, M.D. from Board of Directors
14 Apr 2022 16:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
23 Mar 2022 16:15:00 By Nasdaq GlobeNewswire
-
17 Mar 2022 08:00:01 By Nasdaq GlobeNewswire